
Chris Smith
Advertisement
Chris Smith is Director of Hays Life Sciences.
Articles by Chris Smith

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: Johnson & Johnson Acquires Ollin Biosciences, Eli Lilly Acquires Calytrix Bio, AmyriAD Therpaeutics Acquires AD04 Alzheimers Program, Sanofi Enters Collaboration with Seawolf Therapeutics
2
The Hidden Risk in Pharma’s AI Rush
3
FDA Approves Klygefa for gMG, Gazyva for Primary Membranous Nephropathy, Igalmi for Agitation Associated with Schizophrenia
4
Eli Lilly Breaks Ground on $3.5 billion Pennsylvania Manufacturing Site
5